Advertisement

Drug company expands voluntary recall of infant ibuprofen

Tris Pharma has expanded their nationwide recall of ibuprofen oral suspension drops. Tris Pharma has expanded their nationwide recall of ibuprofen oral suspension drops. | Photo: Tris Pharma.

January 31, 2019 09:56 AM

MONMOUTH JUNCTION, N.J. (AP) - Tris Pharma has expanded its voluntary recall of infant ibuprofen because it may contain overly high concentrations of the drug.

The company, based in Monmouth Junction, New Jersey, announced the move this week.

Advertisement – Content Continues Below

It says the concentration can be as high as 10 percent above the specified limit. The affected brands include CVS health and Equate and are sold at Walmart, CVS and Family Dollar stores.

Infants already susceptible to the adverse effects of ibuprofen could be at a slightly higher risk if given medication from a recalled bottle. There's a remote possibility an elevated level of ibuprofen could lead to permanent kidney damage in babies.

Other potential adverse health effects include nausea, vomiting, stomach pain and diarrhea.

Tris Pharma says it hasn't received any reports of related health problems.

Credits

AP

Copyright 2019 The Associated Press. All rights reserved.

Advertisement
Relay Media Amp
Advertisement
Advertisement
Troy looks to reopen city pool closed for two years

US Postal Service delivers damaged mail from fatal accident

NYC cops, officers' widows in Albany to deliver letters opposing parole for cop killers

Deadly Washington County motorcycle crash under investigation

GOP lawmakers, sheriffs weigh in on driver's license issue

Advertisement